Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia
- PMID: 34935240
- DOI: 10.1111/resp.14194
Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia
Abstract
Background and objective: Idiopathic pulmonary fibrosis (IPF) is one of the most common forms of interstitial lung diseases. While studies have been conducted in other countries to determine the epidemiological burden of IPF, there is limited information in Australia. Our study aimed to address this gap and generate the first estimates for the mortality, incidence and prevalence of IPF in Australia.
Methods: Estimates were generated by utilizing the novel Mortality Incidence Analysis Model (MIAMOD) method and software based on the illness-death model. Data inputs included population estimates and mortality data from the Australian Bureau of Statistics (ABS) for the period 1997-2015 and participant data from the Australian IPF Registry (AIPFR). Projections were estimated for a 10-year period up to 2025.
Results: Overall crude and age-standardized estimates for mortality were 5.9 and 6.3 per 100,000 population; incidence, 10.4 and 11.2 per 100,000 population; and prevalence, 32.6 and 35.1 per 100,000 population. Crude and age-standardized mortality, incidence and prevalence increased over the study period; however, they demonstrated a decreasing trend over the projected period. Persons older than 70 years constituted 9% of the population; however, they accounted for approximately 82%-83% of all deaths, incident and prevalent cases. All estimates were higher in males than in females.
Conclusion: Our study provides the first estimates for incidence, prevalence and mortality of IPF in Australia. By reporting national estimates for IPF, our study addresses an information gap important for policy, planning and to help optimize the allocation of resources for the management of patients with IPF.
Keywords: MIAMOD; Mortality Incidence Analysis Model; burden of disease; epidemiology; idiopathic pulmonary fibrosis; interstitial lung disease; prevalence.
© 2021 Asian Pacific Society of Respirology.
Comment in
-
Piecing together the bigger picture: Idiopathic pulmonary fibrosis in Australia and beyond.Respirology. 2022 Mar;27(3):187-189. doi: 10.1111/resp.14209. Epub 2022 Jan 17. Respirology. 2022. PMID: 35037339 No abstract available.
References
REFERENCES
-
- Olson AL, Yunt ZX, Swigris JJ. Chapter 6 - Idiopathic pulmonary fibrosis: diagnosis and epidemiology. In: Collard HR, Richeldi L, editors. Interstitial lung disease. Philadelphia, USA: Elsevier; 2018. p. 75-85.
-
- Akgun KM, Crothers K, Pisani M. Epidemiology and management of common pulmonary diseases in older persons. J Gerontol A Biol Sci Med Sci. 2012;67(3):276-91.
-
- Khor YH, Ng Y, Barnes H, Goh NSL, McDonald CF, Holland AE. Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review. Eur Respir Rev. 2020;29(157):190158.
-
- Hutchinson J, Fogarty A, Hubbard R, McKeever T. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J. 2015;46(3):795-806.
-
- Hutchinson JP, McKeever TM, Fogarty AW, Navaratnam V, Hubbard RB. Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century. Ann Am Thorac Soc. 2014;11(8):1176-85.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
